Nika Pharmaceuticals, Inc (NIKA) Long-Term Deferred Tax (2021 - 2023)
Nika Pharmaceuticals' (NIKA) quarterly Long-Term Deferred Tax came in at $714000.0 in Q4 2023, up 2.0% YoY from $700000.0 in Q4 2022, and up 2.0% on a QoQ basis from $700000.0 in Q4 2022.
Nika Pharmaceuticals, Inc (NIKA) Long-Term Deferred Tax (2021 - 2023) Analysis & Trends
Nika Pharmaceuticals (NIKA) has 3 years of Long-Term Deferred Tax data on file, last reported at $714000.0 in Q4 2023.
- Quarterly Long-Term Deferred Tax rose 2.0% year-over-year to $714000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $714000.0 (up 2.0% YoY) and the FY2023 annual result came in at $714000.0, up 2.0% from the prior year.
- Long-Term Deferred Tax rose to $714000.0 in Q4 2023, from $700000.0 in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $714000.0 in Q4 2023 to a low of $31857.0 in Q4 2021.
- A 3-year average of $481952.3 and a median of $700000.0 in 2022 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2022 — Long-Term Deferred Tax soared 2097.32% — and 2023, when it climbed 2.0%.
- Tracing NIKA's Long-Term Deferred Tax over 3 years: stood at $31857.0 in 2021, then soared by 2097.32% to $700000.0 in 2022, then grew by 2.0% to $714000.0 in 2023.
- The last three Long-Term Deferred Tax figures came in at $714000.0 (Q4 2023), $700000.0 (Q4 2022), and $31857.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 714,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Dec 31, 2021 | 31,857.00 |